Advertisement

WHO Reveals Its Recommended Vaccine For Use Against COVID-19 Variants

World Health Organization (WHO) has recommended Johnson & Johnson’s (J&J) Coronavirus vaccine for use in countries grappling with highly infectious and deadly variants of SARS-COV-2, the Coronavirus which causes COVID-19 disease.

Advertisement

WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization met earlier this week and recommended the single-shot J&J COVID-19 vaccine that can be stored at regular refrigeration rather than ultra-cold temperatures.


ALSO READ

Punjab’s Hospitals Reach Near-Full Capacities With COVID-19 Patients


According to a statement issued by the Chairman SAGE, Alejandro Cravioto, J&J’s Coronavirus vaccine has demonstrated the necessary safety and efficacy levels to be recommended by the WHO for use in people over the age of 18.

The statement added that the single-dose J&J’s COVID-19 vaccine is 66.9% effective against symptomatic infection, 76.7% effective after 14 days, and 85.4% effective after 28 days.


ALSO READ

KP Issues Special COVID-19 SOPs for Tourist Spots


J&J’s vaccine is the first single-dose and overall third Coronavirus vaccine to be approved by WHO. The other two two-dose Coronavirus vaccines approved by the WHO have been developed by Pfizer-BioNTech and AstraZeneca-Oxford.

Besides, European Union (EU), United States, Canada, and South Africa have so far granted Emergency Use Authorization (EUA) to J&J’s COVID-19 vaccine.

Advertisement
Advertisement

Advertisement

See ProPakistani in...
ProPakistani App
close
>